medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Comments on "Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficultto- treat inflammatory bowel disease: a single-center retrospective study in Japan". Intest Res Xu C, Li H. PMID: 42156081 [PubMed - as supplied by publisher]
	Use Patterns of Novel Janus Kinase Inhibitors After the First Safety Alerts: A Nationwide Register-Based Time Series Analysis. Pharmacoepidemiol Drug Saf Rutanen J, Heino P, Sarnola K, Kurko T. PMID: 42156017 [PubMed - indexed for MEDLINE]
	Acute severe ulcerative colitis: efficacy and safety of jak inhibitors. Expert Opin Pharmacother Bruno A, Bencardino S, D'Amico F, Peyrin-Biroulet L, Danese S. PMID: 42155464 [PubMed - as supplied by publisher]
	Clinicopathological features and cancer-specific survival in young patients with ulcerative colitis-associated colorectal neoplasia: a nationwide cohort study in Japan. Inflamm Bowel Dis Shinagawa T, Komatsu K, Uchino M, Ikeuchi H, Shigeta K, Oka S, Higashi D, Ogawa S, Watanabe K, Shibutani M, Okita Y, Wakai T, Mizuuchi Y, Okamoto K, Yamada K, Sato Y, Ogino T, Kimura H, Takahashi K, Hida K, Kinugasa Y, Ishida F, Okuda J, Daito K, Yamamoto T, Yamamoto S, Koyama F, Hiro J, Komori K, Shida D, Arakaki J, Fujita F, Matsuyama T, Ueno H, Ochiai H, Maemoto A, Nezu R, Sasaki S, Sunami E, Noguchi T, Sugihara K, Ajioka Y, Ishihara S, Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by Japanese Society for Cancer of the Colon and Rectum. PMID: 42154979 [PubMed - as supplied by publisher]
	Patient acceptability of partial enteral nutrition as a concomitant therapy to Adalimumab in adults with active Crohn's disease - BIOPIC trial. Ann Nutr Metab Fandinga C, Clowe J, White B, Campbell I, Seenan JP, Brownson E, Milling S, Koutsos A, Ho GT, Mowat C, Robertson E, Gaya DR, Kefayat A, Din S, MacDonald J, Gerasimidis K. PMID: 42154650 [PubMed - as supplied by publisher]
	Intestinal Epithelial Cell Ferroptosis in Ulcerative Colitis: Pathogenesis, Signaling Networks, and Therapeutic Implications. Curr Med Sci Zhao ZQ, Yu ZX, Liu ZQ, Yu T, Fan H. PMID: 42154151 [PubMed - as supplied by publisher]
	A comparative analysis of corticosteroids and exclusive enteral nutrition induction therapy in children with small bowel Crohn's disease: results of two prospective cohorts. Eur J Pediatr Klomberg RCW, Griffiths AM, Aloi M, Kiparissi F, Lawrence S, Otley AR, Critch J, van der Feen C, Rodrigues A, Mack DR, Huynh HQ, Church PC, Rizopoulos D, Croft NM, de Ridder L, Walters TD, European Paediatric IBD Network for Safety, Efficicacy of Treatment and Quality Improvement of Care (PIBD-SETQuality), Canadian Children IBD Network (CIDsCaNN). PMID: 42154069 [PubMed - indexed for MEDLINE]
	Revolutionizing Crohn's disease detection: integrating AI with intestinal ultrasound for superior diagnosis. Ther Adv Gastroenterol Huang R, Zhong M, Hong C, Liu Z, Chen K, Li X, Lu Q, Liu Q, Li Z, Jiang C, Jian G, Su P. PMID: 42153214 [PubMed]
	Short-term efficacy and safety of infliximab biosimilar (HS626) in inducing remission of inflammatory bowel disease: A real-world single-center study. Medicine (Baltimore) Huang YS, Lai DP, Nong H, Zhang T, Chen ZY, Zeng WB, Huang XP, Lin YY. PMID: 42152434 [PubMed - indexed for MEDLINE]
	Dynamic changes in serum gelsolin combined with clinical parameters to construct a predictive model for mucosal healing in inflammatory bowel disease: A prospective cohort study. Medicine (Baltimore) Zhang Y, Zhao Q, Miao J, Tu J, Wang P, Li A, Li J. PMID: 42152368 [PubMed - indexed for MEDLINE]
	Mendelian randomization analyses explore the relationship between inflammatory bowel disease and genitourinary diseases. Medicine (Baltimore) Cao H, Shi C, Dai X, Yuan B, Yang G, Wang S. PMID: 42152343 [PubMed - indexed for MEDLINE]
	HOCl-Mediated Bromothymol Blue Bleaching and Carbon Dot Fluorescence Recovery for Fecal Myeloperoxidase Quantification in Ulcerative Colitis. J Fluoresc Alasiri G, Alaseem AM, El-Wekil MM, Ali R, Ali ABH. PMID: 42151651 [PubMed - as supplied by publisher]
	Efficacy and Safety of Risankizumab in Crohn's Disease: A Systematic Review and Meta-Analysis of Randomized Trials and Real-World Evidence. Dig Dis Sci Abouelmagd AA, Yassin MN, Abo-Elnour DE, Aboelkhier MM, Hamam NG, Elareef AA, Sayed MS, Gado MI, Elqadi TM, Elazab A, Mousa YM, Gabra MD, Verstockt B. PMID: 42151576 [PubMed - as supplied by publisher]
	Inorganic nitrogen metabolic reprogramming of the gut microbiome drives fecal microbiota transplantation in ulcerative colitis. Nat Commun Wang Y, Hou Q, Lv X, Liu J, Wang H, Zhao Y, Tong H, Liu Y, Du J, Yang X, Wu S, He S, Yang X. PMID: 42151161 [PubMed - as supplied by publisher]
	Efficacy analysis of the Turnbull-Cutait procedure in refractory perianal Crohn's disease: a two-centre retrospective study. Int J Colorectal Dis Tu Q, Hu H, Zhang M, Luo K, Wan S, Li D, Li Y, Ke J, Ding Z. PMID: 42149270 [PubMed - as supplied by publisher]
	Preoperative Biological Therapy and Postoperative Outcomes Following Ileocolic Resection for Crohn's Disease. Isr Med Assoc J Saab H, Perets M, Yellinek S, Ben-Haim M, Freund MR. PMID: 42148613 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of High-Dose Multimatrix Mesalazine in Pediatric Patients with Mild-to-Moderate Active Ulcerative Colitis. Pediatr Gastroenterol Hepatol Nutr Shimizu T, Iwama I, Kakiuchi T, Abukawa D, Kumagai H, Iwata N, Takatsu M, Nishimura K, Matsuda A, Hayashi K, Mizuochi T. PMID: 42148175 [PubMed]
	Maintenance Enteral Nutrition in Paediatric Crohn's Disease: A Systematic Review and Meta-Analysis. Pediatr Gastroenterol Hepatol Nutr Brown SC, Berkouwer B, Vernon-Roberts A, Day AS. PMID: 42148174 [PubMed]
	All roads lead to NF-ÎºB: the NF-ÎºB pathway as a major target for intestinal inflammatory disorders. Front Immunol Khasanov R, Boettcher M, Wessel LM, Schäfer KH, Tapia-Laliena MÁ. PMID: 42148126 [PubMed - indexed for MEDLINE]
	Does aspirin worsen Crohn's disease outcomes? A multicenter propensity-matched cohort study. Proc (Bayl Univ Med Cent) Awuah KB, Guedze K, Onwuzo S, Onwuzo C, Abdel-Razeq R, Ozongwu K, Daniel T. PMID: 42148009 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 57645

Seite 1 von 2883



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung